The effect of seprafilm and interceed on capsule formation around silicone discs in a rat model.
The insertion of a foreign substance, such as a breast implant into mammalian soft tissues, evokes a wound healing response that culminates in a dense connective-tissue envelope or capsule surrounding the implant. Several biodegradable products, such as Seprafilm (carboxymethylcellulose and hyaluronic acid) and Interceed (oxidized regenerated cellulose), have been demonstrated to inhibit adhesions in abdominal and gynecologic surgery. The ability of these cellulose compounds to inhibit capsule formation was addressed in this investigation. Twenty-eight rats were implanted intermuscularly with either plain silicone discs (10 animals), discs wrapped in Seprafilm (10 animals), or discs covered with Interceed (8 animals). Additional control animals (6 animals) consisted of two that had sham operations, two animals implanted with Seprafilm only, and two more implanted with Interceed only. Animals were sacrificed in pairs at varying time intervals after implantation (2, 4, 8, 12, and 16 wk), and the tissues around the silicone discs were analyzed with light microscopy. Control animals were sacrificed at 8 wk. Both Interceed and Seprafilm slowed the formation of a capsule around the implanted silicone discs as both products were degraded. Evidence of residual material, presumably Seprafilm and Interceed, was seen intracellularly in animals 3 to 4 mo, respectively, after implantation. However, neither material prevented the eventual formation of a fibrous capsule around the silicone discs. The results of this study suggest that encapsulating foreign substances with these types of biodegradable materials will not significantly hinder capsule formation. A more direct attack on the wound healing mechanism may provide a definitive solution for capsule problems with implanted materials.
Friedman
H
H
Division of Plastic Surgery, Department of Surgery, University of South Carolina School of Medicine, Columbia, South Carolina 29203, USA. hfriedmandr@sc.rr.com
Stonerock
C
C
Lefaivre
J
J
Yost
M
M
D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology*; D001673:Biodegradation, Environmental; D002483:Cellulose, Oxidized / Q000494:pharmacology*; D006820:Hyaluronic Acid; D020007:Implants, Experimental; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012828:Silicones; D014945:Wound Healing / Q000187:drug effects*
D001672:Biocompatible Materials; D002483:Cellulose, Oxidized; C060002:INTERCEED; C118198:Seprafilm; D012828:Silicones; D006820:Hyaluronic Acid